Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998–2003)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bantar, 2002, Acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from a South American working group (ConsenSur), J. Chemother., 14, 635, 10.1179/joc.2002.14.6.635
Barradell, 1994, Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use, Drugs, 47, 471, 10.2165/00003495-199447030-00007
Bouza, 2000, Monotherapy versus combination therapy for bacterial infections, Med. Clin. North Am., 84, 1357, 10.1016/S0025-7125(05)70293-5
Carmeli, 1999, Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents, Antimicrob. Agents Chem., 43, 1379, 10.1128/AAC.43.6.1379
Chapman, 2003, Cefepime: A review of its use in the management of hospitalized patients with pneumonia, Am. J. Respir. Medicine, 2, 75, 10.1007/BF03256641
2005
Hanberger, 2001, Surveillance of antibiotic resistance in European ICUs, J. Hosp. Infect., 48, 161, 10.1053/jhin.2001.0987
Harris, 2002, Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients, Clin. Infect. Dis., 34, 340, 10.1086/338237
Ibrahim, 2000, The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting, Chest, 118, 146, 10.1378/chest.118.1.146
Jones, 2001, Resistance patterns among nosocomial pathogens. Trends over the past few years, Chest, 119, 397S, 10.1378/chest.119.2_suppl.397S
Jones, 2002, Antimicrobial activity of broad-spectrum agents tested against gram-negative bacilli resistant to ceftazidime: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2001), Diagn. Microbiol. Infect. Dis, 44, 379, 10.1016/S0732-8893(02)00442-X
Kessler, 2001, Cefepime microbiologic profile and update, Pediatr. Infect. Dis. J., 20, 331, 10.1097/00006454-200103000-00031
Mandell, 2003, Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Infectious Diseases Society of America, Clin. Infect. Dis., 37, 1405, 10.1086/380488
2003
Newhauser, 2003, Antibiotic resistance among gram-negative bacilli in US intensive care units, JAMA, 289, 885, 10.1001/jama.289.7.885
Sader, 2003, Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997–2001), Diagn. Microbiol. Infect. Dis., 47, 361, 10.1016/S0732-8893(03)00052-X
Sader, 1992, Historical overview of the cephalosporin spectrum: Four generations of structural evolution, Antimicrob. Newsl., 8, 75, 10.1016/0738-1751(92)90022-3